Legal Options Are Being Evaluated By Glenmark After Its Diabetes Drug Setback

by Reshma Anand on  October 10, 2015 at 4:57 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

Drug firm Glenmark Pharmaceuticals is evaluating legal options after the Delhi High Court restrained it from manufacturing and selling generic version of MSD's anti-diabetes medicines Januvia and Janumet.
Legal Options Are Being Evaluated By Glenmark After Its Diabetes Drug Setback
Legal Options Are Being Evaluated By Glenmark After Its Diabetes Drug Setback

"Glenmark accepts the Honorable High Court's decision. However the decision can be appealed and Glenmark is evaluating the possible legal options," the company said.

As per the High Court's Order, "Glenmark has been restrained by a decree of permanent injunction from making, using, selling, distributing, advertising, exporting, offering for sale or dealing in Sitagliptin Phosphate Monohydrate or any other salt of Sitagliptin in any form, alone or in combination with one or more other drugs".

Pharma major MerckSharp and Dohme (MSD) in its plea had sought injunction against Glenmark alleging that the Indian pharma company had violated its IPR over its anti-diabetes medicines, Januvia and Janumet, by coming out with their own drugs containing the same salts.

Source: PTI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Signature Drug Toxicity Stress Relief Through Alternative Medicine 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive